| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| H C Fibiger, A G Phillips, E E Brow. The neurobiology of cocaine-induced reinforcement. Ciba Foundation symposium. vol 166. 1992-09-03. PMID:1638924. |
similarly, selective lesions of dopaminergic terminals in the nucleus accumbens, a major target of the mesolimbic dopamine projection, disrupt cocaine self-administration in a manner that is consistent with loss of cocaine-induced reward. |
1992-09-03 |
2023-08-11 |
Not clear |
| K Kadowaki, K Hirota, K Koike, M Ohmichi, A Miyake, O Tanizaw. Atrial and brain natriuretic peptides enhance dopamine accumulation in cultured rat hypothalamic cells including dopaminergic neurons. Neuroendocrinology. vol 56. issue 1. 1992-09-02. PMID:1386413. |
atrial and brain natriuretic peptides enhance dopamine accumulation in cultured rat hypothalamic cells including dopaminergic neurons. |
1992-09-02 |
2023-08-11 |
rat |
| D J Calcagnetti, M D Schechte. Attenuation of drinking sweetened water following calcium channel blockade. Brain research bulletin. vol 28. issue 6. 1992-08-28. PMID:1386279. |
by blocking voltage-dependent l-type calcium channels, isr may regulate neural dopamine release that, in turn, decreases the putative rewarding effects mediated by dopaminergic mechanisms. |
1992-08-28 |
2023-08-11 |
rat |
| D Nakahara, K Fuchikami, N Ozaki, T Iwasaki, T Nagats. Differential effect of self-stimulation on dopamine release and metabolism in the rat medial frontal cortex, nucleus accumbens and striatum studied by in vivo microdialysis. Brain research. vol 574. issue 1-2. 1992-08-28. PMID:1638391. |
changes in the extracellular levels of dopamine (da) and its metabolites in the dopaminergic terminal regions, the medial frontal cortex (mfc), nucleus accumbens (nac), and striatum (str), were measured by microdialysis during self-stimulation of the medial forebrain bundle (mfb) in rats pretreated with the da uptake inhibitor, nomifensine (1 mg/kg, i.p.). |
1992-08-28 |
2023-08-11 |
rat |
| J H Carlson, S L Foot. Oscillation of interspike interval length in substantia nigra dopamine neurons: effects of nicotine and the dopaminergic D2 agonist LY 163502 on electrophysiological activity. Synapse (New York, N.Y.). vol 11. issue 3. 1992-08-24. PMID:1636152. |
oscillation of interspike interval length in substantia nigra dopamine neurons: effects of nicotine and the dopaminergic d2 agonist ly 163502 on electrophysiological activity. |
1992-08-24 |
2023-08-11 |
rat |
| C Heidbreder, M Gewiss, S Lallemand, B P Roques, P De Witt. Inhibition of enkephalin metabolism and activation of mu- or delta-opioid receptors elicit opposite effects on reward and motility in the ventral mesencephalon. Neuropharmacology. vol 31. issue 3. 1992-08-20. PMID:1321359. |
the coexistence of endogenous opioid systems and dopaminergic neurones in the midbrain tegmental area suggests functional interactions between dopamine and enkephalins. |
1992-08-20 |
2023-08-11 |
rat |
| A Zuddas, G Oberto, F Vaglini, F Fascetti, F Fornai, G U Corsin. MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. Journal of neurochemistry. vol 59. issue 2. 1992-08-20. PMID:1629743. |
mk-801 also attenuated dopamine depletion in the caudate and putamen and protected dopaminergic neurons in the substantia nigra from the degeneration induced by the neurotoxin. |
1992-08-20 |
2023-08-11 |
monkey |
| D G Kirch, T R Taylor, I Creese, S X Xu, R J Wyat. Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors. The Journal of pharmacy and pharmacology. vol 44. issue 2. 1992-08-19. PMID:1352822. |
although nicotine has been shown to affect nigrostriatal dopamine release, chronic treatment does not appear to alter overall striatal dopaminergic receptor binding parameters. |
1992-08-19 |
2023-08-11 |
rat |
| M F Casanova, S O Comparini, R W Kim, J E Kleinma. Staining intensity of brain iron in patients with schizophrenia: a postmortem study. The Journal of neuropsychiatry and clinical neurosciences. vol 4. issue 1. 1992-08-19. PMID:1627959. |
evidence derived from both pharmacological and postmortem studies suggests that a disturbance of brain iron metabolism is involved in the pathophysiology of schizophrenia; i.e., the distribution of iron parallels that of dopamine, and variations in its brain concentration selectively modulate the binding affinity of the dopaminergic (d2) receptor. |
1992-08-19 |
2023-08-11 |
Not clear |
| I J Mitchell, S Boyce, M A Sambrook, A R Crossma. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia. Brain : a journal of neurology. vol 115 ( Pt 3). 1992-08-19. PMID:1628204. |
the remaining animals spent an equivalent period of time relatively unexposed to dopaminergic agents, receiving only therapeutic doses, and at no time showed any signs of dopamine agonist-induced dyskinesia. |
1992-08-19 |
2023-08-11 |
monkey |
| K A Gary, B M Chronwal. The onset of dopaminergic innervation during ontogeny decreases melanotrope proliferation in the intermediate lobe of the rat pituitary. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience. vol 10. issue 2. 1992-08-18. PMID:1352934. |
the onset of innervation and increased dopamine concentration suggests increased dopaminergic control of the melanotropes, illustrated specifically by a decrease in their level of proliferation. |
1992-08-18 |
2023-08-11 |
rat |
| J A Skrinskaya, E M Nikulina, N K Popov. Role of genotype in brain dopamine metabolism and dopamine-dependent behavior of mice. Pharmacology, biochemistry, and behavior. vol 42. issue 2. 1992-08-17. PMID:1385878. |
in mice of eight inbred strains--balb/c, akr/j, dba/2, cba, c57b1/6, dd, cc57br, and c3h/he--brain dopamine and its metabolites, 3,4-dihydroxyphenylacetic acid (dopac) and homovanillic acid (hva), in striatum and nucleus accumbens with tuberculum olfactorium, the structures of two main dopaminergic systems--nigrostriatal and mesolimbic--were determined. |
1992-08-17 |
2023-08-11 |
mouse |
| J A Skrinskaya, E M Nikulina, N K Popov. Role of genotype in brain dopamine metabolism and dopamine-dependent behavior of mice. Pharmacology, biochemistry, and behavior. vol 42. issue 2. 1992-08-17. PMID:1385878. |
in both dopaminergic regions, no strain effect on either dopamine or dopac levels was found, while for hva content a highly significant hereditary determination was shown. |
1992-08-17 |
2023-08-11 |
mouse |
| D L Rosin, W A Clark, M Goldstein, R H Roth, A Y Deutc. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience. vol 48. issue 4. 1992-08-14. PMID:1352864. |
6-hydroxydopamine lesions of the dopaminergic innervation of the prefrontal cortex did not alter concentrations of dopamine or its metabolite 3,4-dihydroxyphenylacetic acid in either the striatum or nucleus accumbens. |
1992-08-14 |
2023-08-11 |
human |
| D L Rosin, W A Clark, M Goldstein, R H Roth, A Y Deutc. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience. vol 48. issue 4. 1992-08-14. PMID:1352864. |
these data suggest that lesions of the prefrontal cortical dopamine innervation do not result in significant alterations in basal dopaminergic function in the striatal complex. |
1992-08-14 |
2023-08-11 |
human |
| D L Rosin, W A Clark, M Goldstein, R H Roth, A Y Deutc. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience. vol 48. issue 4. 1992-08-14. PMID:1352864. |
however, lesions of the dopaminergic innervation of the prefrontal cortex significantly increase the responsiveness of mesolimbic dopamine afferents to pharmacological challenge. |
1992-08-14 |
2023-08-11 |
human |
| U M Schrell, P Nomikos, R Fahlbusc. Presence of dopamine D1 receptors and absence of dopamine D2 receptors in human cerebral meningioma tissue. Journal of neurosurgery. vol 77. issue 2. 1992-08-13. PMID:1385626. |
competition curves reveal the presence of a dopamine d1 receptor by rank order of various dopaminergic and nondopaminergic antagonists ((+)-sch-23390 greater than (+/-)-skf-83566 greater than (cis)-flupentixol greater than (+)-butaclamol greater than chlorpromazine greater than 1-sulpiride greater than mianserin greater than (-)-butaclamol). |
1992-08-13 |
2023-08-11 |
human |
| D Zieba, T Wegrzyn, E Cebrat, Z Leroc. [Effect of dopamine on cecum motility in sheep]. Polskie archiwum weterynaryjne. vol 31. issue 1-2. 1992-08-13. PMID:1821029. |
it has been concluded that dopamine inhibits the caecum motility in sheep through specific dopaminergic receptors. |
1992-08-13 |
2023-08-11 |
Not clear |
| P Mitchell, L Selbie, B Waters, J Donald, C Vivero, M Tully, J Shin. Exclusion of close linkage of bipolar disorder to dopamine D1 and D2 receptor gene markers. Journal of affective disorders. vol 25. issue 1. 1992-08-11. PMID:1385598. |
a potential role of dopamine in bipolar disorder has been suggested by several strands of evidence, namely the ability of dopaminergic agonists to induce mania and the effects of lithium, carbamazepine and the antipsychotics on central dopamine receptors and/or turnover. |
1992-08-11 |
2023-08-11 |
Not clear |
| S Shimada, S Kitayama, D Walther, G Uh. Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Brain research. Molecular brain research. vol 13. issue 4. 1992-08-10. PMID:1352613. |
different dopaminergic cell groups display different levels of dat1 dopamine transporter expression. |
1992-08-10 |
2023-08-11 |
Not clear |